EMBRYONAL RHABDOMYOSARCOMA
Clinical trials for EMBRYONAL RHABDOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new EMBRYONAL RHABDOMYOSARCOMA trials appear
Sign up with your email to follow new studies for EMBRYONAL RHABDOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could adding temsirolimus boost chemo for kids and young adults with muscle cancer?
Disease control OngoingThis study compares standard chemotherapy (VAC/VI) to the same chemo plus temsirolimus in people up to age 40 with intermediate-risk rhabdomyosarcoma, a type of muscle cancer. The goal is to see if adding temsirolimus improves event-free survival and overall survival. Participant…
Matched conditions: EMBRYONAL RHABDOMYOSARCOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New drug combo aims to beat tough childhood cancer
Disease control OngoingThis study tests whether adding a drug called vinorelbine to standard chemotherapy can help children and young adults with high-risk rhabdomyosarcoma, a rare muscle cancer. About 118 participants will receive either the standard treatment or the new combination, followed by maint…
Matched conditions: EMBRYONAL RHABDOMYOSARCOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 01, 2026 15:56 UTC